|William M. Armstead||Anesthesia and Critical Care||traumatic brain injury, stroke
||Dr. Armstead's research focuses on characterizing mechanisms important in the control of cerebral hemodynamics under physiologic and pathologic conditions such as traumatic brain injury (TBI), stroke, and cerebral hypoxia/ischemia, particularly in the newborn.
|David Artis||Microbiology||immunology, cell biology, parasitic helminth infections
||The goals of the Artis lab are to understand the regulatory mechanisms that control immune cell homeostasis at the body's barrier surfaces.
|Paul Bates||Microbiology||retroviruses, ebola virus, hepatitis C, SARS
||The Bates lab is interested in the interactions between viruses and their host cells. We use a combination of molecular, cell biological, and genetic tools to understand how viruses invade host cells and evade host defenses.
|Michael Betts||Microbiology||HIV pathogenesis, T-cells, vaccines
||The Betts laboratory studies the cellular immune response to pathogens in humans, non-human primates, and mice.Our primary interest focuses on the role of HIV-specific T cell responses in HIV infected individuals.
|Rosette C. Biester||Physical Medicine and Rehabilitation||truamatic brain injury, stroke, cognitive impairments
||Dr. Biester's research has focused on the comprehensive assessment of neurocognitive impairments, mood disturbance, quality of life, and functional/behavioral changes associated with traumatic brain injuries, stroke, and pulmonary conditions including acute respiratory distress syndrome and pulmonary hypertension.
|Frederic Bushman||Microbiology||HIV, gene therapy
||Research in the Bushman laboratory focuses on host-microbe interactions in health and disease, with particular focus on studies of 1) the human microbiome, 2) HIV pathogenesis, and 3) DNA integration in human gene therapy.
|Sara Cherry||Microbiology||virus, innate immunity, Drosophila
||Research in the Cherry lab is aimed at identifying cellular factors that regulate viral pathogenesis, including both those factors hijacked by viruses for replication and those innate anti-viral mechanisms used by the host to combat the invader.
|Akiva S. Cohen||Neurology||concussive brain injury, hippocampus, cognitive impairment, dietary intervention
||Dr. Cohen's principal research interest is focused on the fundamental cellular and molecular mechanisms that underlie cognitive impairments associated with traumatic brain injury. His laboratory is primarily concerned with alterations in neuronal excitability in the limbic system of the brain.
|D. Kacy Cullen||Neurosurgery||neurotrauma, traumatic brain injury, regeneration
||The Cullen Laboratory applies Neural Engineering principles and technologies to the area of Neurotrauma. A biomedical engineering approach is used to better understand the causative mechanisms of neural injury as well as to develop cutting-edge neural tissue engineering-based treatments to promote regeneration and restore function.
|John Detre||Radiology||fMRI, functional neuroimaging
||Dr. Detre's research focuses on imaging brain function using magnetic resonance and other physiological imaging modalities.
|Nigel Fraser||Microbiology||HSV-1 latency
||Using the techniques of molecular biology, we have studied HSV-1 latency in a mouse model system. My group has shown that the physical state of the latent viral DNA is episomal and not integrated, and that it is harbored in the trigeminal ganglia and brain stem of latently infected mice.
|M. Sean Grady||Neurosurgery||brain recovery, memory function, traumatic brain injury, anti-convulsants
||His laboratory work in conjunction with the Center for Brain Injury and Repair, uses laboratory models to help identify mechanisms that underlie brain recovery, particularly recovery of memory function.
|Akira Kaji||Microbiology||prokaryotic protein synthesis
||We study protein synthesis. Protein synthesis consists of four steps; initiation, elongation, termination and recycling of ribosomes for new round of translation.
|Yvonne Paterson||Microbiology||immuno therapies, cancer, infectious diseases
||The research performed in the Paterson laboratory is dedicated to harnessing the immune system to provide cures for, or protection against, neoplastic and infectious disease.
|James Riley||Microbiology||cancer, HIV, T cell therapeutics
||Research in the Riley laboratory focuses on the cell biology of and therapeutic use of primary human T cells.
|Erle S. Robertson||Microbiology||mechanisms of oncogenesis by gammaherpesvirus
||Epstein-Barr virus (EBV) and Kaposi's sarcoma associated herpesvirus (KSHV) are associated with a number of human malignancies.
|Robert Siman||Neurosurgery||neurodegeneration, traumatic brain injury
|| His work focuses on families of enzymes (proteases) implicated in the neurodegeneration following traumatic brain injury and stroke, as well as neuronal proteins measurable in the blood that serve as noninvasive surrogate measures for the diagnosis, prognosis, mechanistic and therapeutic evaluation of acute brain damage.
||The Smith Neurotrauma Laboratory focuses on the mechanical events at the time of brain injury and how they relate to long-term outcome. It specifically concentrates on the fate of nerve fibers in the brain, called "axons," that appear to be exquisitely vulnerable to trauma.
|John Wolf||Neurosurgery||electrophysiology, neurotrauma
||In collaboration with Drs. Smith and Cullen, Dr. Wolf is also leading the electrophysiological efforts to integrate electrodes with nervous tissue in vitro so that it can then be implanted for both peripheral and central nervous system repair (Neural Engineering).